The aim of this study was to determine the effects of GHRH antagonists, JMR-132 and JV-1-38, on different processes such as proliferation, apoptosis and cell cycle involved in the progression of prostate cancer in an experimental model of androgen-independent cell PC3 tumors and prostate tumor cell lines. Here, GHRH is linked to prostate cancer.